Nusantara Sejahtera Raya Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Nusantara Sejahtera Raya Tbk. trades at Rp95 (market cap 8T, 20.45M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Nusantara Sejahtera Raya Tbk. is far larger — about 17× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 20.45M). Which is the better fit depends on your goals.
| CNMA | PRDL | |
|---|---|---|
Market Cap | 8T | 470.58B |
Volume | 20.45M | 28.43M |
Lot | 204.52K | 284.34K |
Turnover | 1.97B | 7.8B |
Average Price | 96.33 | 274.19 |
Value | 1.97B | 7.8B |
Indicative Equilibrium Price | 95 | 270 |
Indicative Equilibrium Volume | 5.9K | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Nusantara Sejahtera Raya Tbk. (the “Company”) an Indonesian domiciled company, established on 7 June 1988 by deed of establishment No. 67, drawn up by Benny Kristianto, S.H. The Company commenced its commercial operations in 1989.
Read more on CNMA →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →